Cart
0

Peripheral Artery Disease Market by Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Peripheral Accessories) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_174315
Pages: 150
Sep 2017 | 1539 Views
 
Author's : Prateeksha Kaul & Pallavi Jaiswal
Tables: 55
Charts: 29
 

Peripheral Artery Disease Market Overview:

Global Peripheral Artery Disease Market was valued at $3,136 million in 2016, and is estimated to reach $4,980 million by 2023, growing at a CAGR of 6.8% from 2017 to 2023. Peripheral artery disease is a circulatory disease in which plaque builds up in the arteries carrying blood from heart to legs, arms, and other limbs. Increase in incidence of population suffering from diabetes and high blood pressure which poses a high risk factor for peripheral artery disease drives the market growth. In addition, favorable reimbursement scenario for peripheral artery disease treatment and introduction of advanced treatment products such as drug-eluting stents boost the market growth. However, the issue of restenosis (reoccurrence of peripheral artery disease even after the treatment) impedes the market growth.

Rise in Geriatric Population

There is an increase in the number of aging population worldwide. According to a WHO report, around 524 million people were above 65 years in 2010, and the number is expected to reach 1.5 billion by 2050; which is estimated to constitute about 16% of the total world population. Moreover, there is a positive correlation between elderly individuals and increase in incidence of disorders such as diabetes and hypertension, which in turn increases the risk for peripheral artery disease. Hence, increase in geriatric population is expected to have a positive impact on the market.

Growth in Asia-Pacific Region

Asia-Pacific offers lucrative opportunities for the market growth, owing to presence of large pool of patients suffering from peripheral arterial disease. In addition, increase in awareness among patients regarding the new interventional treatment options such as atherectomy procedure has further increased the peripheral artery disease market in Asia.

Advanced Treatment Options

The market for peripheral artery disease witnesses a huge increase owing to the advanced treatment options such as atherectomy devices, which is used to debulk plaque before treatment with a stent. Therefore, with increase in prevalence of calcified and hard lessions and improving atherectomy procedure, the market is expected to grow in the near future. In addition, other new interventional products such as drug coated balloon stents and drug eluting stents also fuel the market growth.

Global Peripheral Artery Disease: Market Segmentation

GLOBAL PERIPHERAL ARTERY DISEASE: MARKET SEGMENTATION

Get more information on this report : Request Sample Pages

The global peripheral artery disease market is segmented on the basis of type and region. Based on type, the market is divided into peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key companies operating in the market include Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Cardinal Health, Inc., C. R. Bard, Inc., Medtronic plc, Terumo Corporation, The Spectranetics Corporation, AngioDynamics, Inc., BIOTRONIK, and B. Braun Melsungen AG.

South Africa: Peripheral Artery Disease Market, 2016-2023 ($Million)

South Africa: Peripheral Artery Disease Market, 2016-2023 ($Million)

Get more information on this report : Request Sample Pages

Key Benefits :

  • The study provides an in-depth analysis of the global peripheral artery disease market, with current trends and future estimations, to elucidate the imminent investment pockets.
  • Quantitative analysis from 2016 to 2023 is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Peripheral Artery Disease Market Key Segments:

By Type

  • Peripheral Angioplasty Balloons
    • Old/Normal Balloons
    • Cutting and Scoring Balloons
    • Drug-Coated Balloons
  • Peripheral Stents
    • Self-expandable
    • Balloon-expandable
    • Covered
    • Drug-eluting Stents
  • Peripheral Catheters
    • Angiography Catheters
    • Guiding Catheters
  • Inferior Vena Cava (IVC) Filters
    • Permanent Filters
    • Retrievable Filters
  • Plaque Modification Devices
    • Thrombectomy Devices
      • Mechanical Thrombectomy Devices
      • Aspiration Thrombectomy Devices
      • Rheolytic Thrombectomy Devices
    • Atherectomy Devices
  • Hemodynamic Flow Alteration Devices
    • Embolic Protection Devices
    • Chronic Total Occlusion Devices
  • Peripheral Accessories
    • Vascular Closure Devices
    • Introducer Sheaths
    • Guidewires
    • Balloon Inflation Devices

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Growing geriatric population and increasing prevalence of chronic diseases
3.3.1.2. Introduction of advanced interventional products
3.3.1.3. Improvement of healthcare infrastructure in developing countries
3.3.1.4. Improved insurance and reimbursement

3.3.2. Restraints

3.3.2.1. Restenosis
3.3.2.2. Stringent approval process for stents

3.3.3. Opportunities

3.3.3.1. Market opportunities in developing countries

3.3.4. Impact analysis

3.4. MARKET SHARE ANALYSIS, 2016
3.5. GOVERNMENT REGULATIONS
3.6. CLINICAL TRIALS

Chapter: 4 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PERIPHERAL ANGIOPLASTY BALLOONS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Old/Normal Balloons

4.2.4.1. Market size and forecast

4.2.5. Cutting and Scoring Balloons

4.2.5.1. Market size and forecast

4.2.6. Drug-Coated Balloons

4.2.6.1. Market size and forecast

4.3. PERIPHERAL STENTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Self-expandable

4.3.4.1. Market size and forecast

4.3.5. Balloon-expandable

4.3.5.1. Market size and forecast

4.3.6. Covered stents

4.3.6.1. Market size and forecast

4.3.7. Drug-eluting Stents

4.3.7.1. Market size and forecast

4.4. ANGIOPLASTY CATHETERS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Angiography Catheters

4.4.4.1. Market size and forecast

4.4.5. Guiding Catheters

4.4.5.1. Market size and forecast

4.5. INFERIOR VENA CAVA (IVC) FILTERS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Permanent Filters

4.5.4.1. Market size and forecast

4.5.5. Retrievable Filters

4.5.5.1. Market size and forecast

4.6. PLAQUE MODIFICATION DEVICES

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Thrombectomy Devices

4.6.4.1. Market size and forecast
4.6.4.2. Mechanical Thrombectomy Devices
4.6.4.3. Market size and forecast
4.6.4.4. Aspiration Thrombectomy Devices
4.6.4.5. Market size and forecast
4.6.4.6. Rheolytic Thrombectomy Devices
4.6.4.7. Market size and forecast

4.6.5. Atherectomy Devices

4.6.5.1. Market size and forecast

4.7. HEMODYNAMIC FLOW ALTERATION DEVICES

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
4.7.4. Embolic Protection Devices

4.7.4.1. Market size and forecast

4.7.5. Chronic Total Occlusion Devices

4.7.5.1. Market size and forecast

4.8. PERIPHERAL ACCESSORIES

4.8.1. Key market trends
4.8.2. Growth factors and opportunities
4.8.3. Market size and forecast
4.8.4. Peripheral vascular Closure Devices

4.8.4.1. Market size and forecast

4.8.5. Introducer Sheaths

4.8.5.1. Market size and forecast

4.8.6. Guidewires

4.8.6.1. Market size and forecast

4.8.7. Balloon Inflation Devices

4.8.7.1. Market size and forecast

Chapter: 5 PERIPHERAL ARTERY DISEASE MARKET, BY REGION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. U.S.
5.2.5. Canada
5.2.6. Mexico

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Germany
5.3.5. France
5.3.6. UK
5.3.7. Italy
5.3.8. Spain
5.3.9. Rest of Europe

5.4. ASIA-PACFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Japan
5.4.5. China
5.4.6. India
5.4.7. Australia
5.4.8. Rest of Asia-Pacific

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.4. Brazil
5.5.5. South Africa
5.5.6. Saudi Arabia
5.5.7. Rest of LAMEA

Chapter: 6 COMPANY PROFILES

6.1. ABBOTT LABORATORIES

6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves and developments

6.2. BOSTON SCIENTIFIC CORPORATION

6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Business performance
6.2.4. Key strategic moves and developments

6.3. COOK

6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Business performance
6.3.4. Key strategic moves and developments

6.4. CARDINAL HEALTH, INC.

6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves and developments

6.5. C. R. BARD, INC.

6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves and developments

6.6. MEDTRONIC PLC

6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves and developments

6.7. TERUMO CORPORATION

6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves and developments

6.8. SPECTRANETICS

6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves and developments

6.9. ANGIODYNAMICS

6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves and developments

6.10. BIOTRONIK

6.10.1. Company overview
6.10.2. Operating business segments
6.10.3. Business performance
6.10.4. Key strategic moves and developments

6.11. B. BRAUN MELSUNGEN AG

6.11.1. Company overview
6.11.2. Operating business segments
6.11.3. Business performance
6.11.4. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 2. PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 3. PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 4. PERIPHERAL STENTS MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 5. PERIPHERAL STENTS MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 6. ANGIOPLASTY CATHETERS, BY TYPE, 2016-2023, ($MILLION)
TABLE 7. ANGIOPLASTY CATHETERS, BY REGION, 2016-2023, ($MILLION)
TABLE 8. INFERIOR VENA CAVA (IVC) FILTERS, BY TYPE, 2016-2023, ($MILLION)
TABLE 9. INFERIOR VENA CAVA (IVC) FILTERS, BY REGION, 2016-2023, ($MILLION)
TABLE 10. PLAQUE MODIFICATION DEVICES, BY TYPE, 2016-2023, ($MILLION)
TABLE 11. PLAQUE MODIFICATION DEVICES, BY REGION, 2016-2023, ($MILLION)
TABLE 12. THROMBECTOMY DEVICES, BY TYPE, 2016-2023, ($MILLION)
TABLE 13. THROMBECTOMY DEVICES, BY REGION, 2016-2023, ($MILLION)
TABLE 14. HEMODYNAMIC FLOW ALTERATION DEVICES, BY TYPE, 2016-2023, ($MILLION)
TABLE 15. HEMODYNAMIC FLOW ALTERATION DEVICES, BY REGION, 2016-2023, ($MILLION)
TABLE 16. PERIPHERAL ACCESSORIES MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 17. PERIPHERAL ACCESSORIES MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 18. PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 19. NORTH AMERICA PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 20. NORTH AMERICA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 21. U.S. PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 22. CANADA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 23. MEXICO PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 24. EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 25. EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 26. GERMANY PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 27. FRANCE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 28. UK PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 29. ITALY PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 30. SPAIN PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 31. REST OF EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 32. ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 33. ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 34. JAPAN PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 35. CHINA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 36. INDIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 37. AUSTRALIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 38. REST OF ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 39. LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 40. LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 41. BRAZIL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 42. SOUTH AFRICA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 43. SAUDI ARABIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 44. REST OF LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 45. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 46. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 47. COOK: COMPANY SNAPSHOT
TABLE 48. CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 49. C. R. BARD: COMPANY SNAPSHOT
TABLE 50. MEDTRONIC: COMPANY SNAPSHOT
TABLE 51. TERUMO: COMPANY SNAPSHOT
TABLE 52. SPECTRANETICS: COMPANY SNAPSHOT
TABLE 53. ANGIODYNAMICS: COMPANY SNAPSHOT
TABLE 54. BIOTRONIK: COMPANY SNAPSHOT
TABLE 55. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. PERIPHERAL ARTERY DISEASE MARKET SEGMENTATION
FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014–2016)
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 5. TOP INVESTMENT POCKETS
FIGURE 6. IMPACT ANALYSIS, 2016
FIGURE 7. MARKET SHARE ANALYSIS, 2016
FIGURE 8. TOTAL NUMBER OF CLINICAL TRIALS IN PERIPHERAL ARTERY DISEASE MARKET
FIGURE 9. OLD/NORMAL BALLOONS MARKET, 2016-2023 ($MILLION)
FIGURE 10. CUTTING AND SCORING BALLOONS MARKET, 2016-2023 ($MILLION)
FIGURE 11. DRUG-COATED BALLOONS MARKET, 2016-2023 ($MILLION)
FIGURE 12. SELF-EXPANDABLE MARKET, 2016-2023 ($MILLION)
FIGURE 13. BALLOON-EXPANDABLE MARKET, 2016-2023 ($MILLION)
FIGURE 14. COVERED STENTS MARKET, 2016-2023 ($MILLION)
FIGURE 15. DRUG-ELUTING STENTS MARKET, 2016-2023 ($MILLION)
FIGURE 16. ANGIOGRAPHY CATHETERS MARKET, 2016-2023 ($MILLION)
FIGURE 17. GUIDING CATHETERS MARKET, 2016-2023 ($MILLION)
FIGURE 18. PERMANENT FILTERS MARKET, 2016-2023 ($MILLION)
FIGURE 19. RETRIEVABLE FILTERS MARKET, 2016-2023 ($MILLION)
FIGURE 20. MECHANICAL THROMBECTOMY DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 21. MECHANICAL THROMBECTOMY DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 22. MECHANICAL THROMBECTOMY DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 23. ATHERECTOMY DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 24. EMBOLIC PROTECTION DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 25. CHRONIC TOTAL OCCLUSION DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 26. PERIPHERAL VASCULAR CLOSURE DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 27. INTRODUCER SHEATHS MARKET, 2016-2023 ($MILLION)
FIGURE 28. GUIDEWIRES MARKET, 2016-2023 ($MILLION)
FIGURE 29. BALLOON INFLATION DEVICES MARKET, 2016-2023 ($MILLION)

 

Globally, peripheral arterial disease, a common circulatory problem in which the blood flow to limbs is highly reduced, constitute a major proportion of health and economic burden. Change in lifestyle, medications, and surgery are some of the effective treatment options of this disease.

Upsurge in the incidence of population suffering from diabetes and high blood pressure increases the risk for peripheral artery disease, which in turn boosts the market. Moreover, obesity and excessive cigarette smoking also multiplies the risk for peripheral artery disease, which further propels the market growth. In addition, introduction of innovative treatment options such as atherectomy and drug-eluting stenting further leads to the growth of the market.

Asia-Pacific offers lucrative opportunities for the market growth due to rapid increase in geriatric population coupled with rise in incidence of peripheral arterial disease. Thus, emerging countries, such as China and India, possess high growth potential for the market.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Peripheral Artery Disease Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3690
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4099
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $4999
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6004
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8373
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo